The medicines decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee April 2025 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG at its March 2025 meeting and NICE Technology appraisals from the 1st December 2024 to 31st January 2025.
The following new guidelines were approved and can be found at:
- NENC Primary Care Management of Adult Vitamin D Deficiency – https://ntag.nhs.uk/guidelines/
- NENC Guidance on Seven-Day Prescriptions and Monitored Dosage Systems (MDS) – https://ntag.nhs.uk/guidelines/
- North East and North Cumbria Do Not Prescribe List – https://ntag.nhs.uk/recommendations/miscellaneous-recommendations/
- North East North Cumbria (NENC) ICB Medicines Committee Position Statement on Prescribing in Persistent Pain – reviewed and updated – https://ntag.nhs.uk/recommendations/central-nervous-system-recommendations/